• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?
By BRUCE KAMICH
Mar 04, 2019 | 08:18 AM EST
Stocks quotes in this article: TNDM, MDT, DXCM

For his "Executive Decision" segment on Friday's Mad Money program, Jim Cramer sat down with Kim Blickenstaff, executive chairman of Tandem Diabetes Care (TNDM) , a stock that has soared an incredible 1,942% over the past year. Blickenstaff said that Tandem has the best touchscreen insulin pump on the market and after consolidation in the industry, now exists in a duopoly with only Medtronic (MDT) .

Blickenstaff added that Tandem has taken a consumer electronics approach to diabetes management, making sleek, stylish products. The latest technology and algorithms do most of the work managing insulin, leaving the patient to mostly just monitor the results. Tandem has also partnered with DexCom (DXCM) , which makes the latest technology in blood glucose monitoring.

As the stock has been rising, the company has been issuing additional shares using the proceeds to pay down debt so now it is a debt-free company. Sounds like promising fundamentals but are we late to the game with the stock up so much? Let's check out the charts this morning.

In this daily bar chart of TNDM, below, we can see that prices rallied from $5 to over $50 in just a little over six months. The stock consolidated those gains until last month when TNDM broke out to new highs with an upside breakaway gap. Notice how the volume of trading expanded from March to September? That's good confirmation of the price action with volume.

Volume dried up during the sideways consolidation patter through February but the On-Balance-Volume (OBV) line remained steady telling us that the longs did not liquidate (sell).

The Moving Average Convergence Divergence (MACD) oscillator has confirmed the price action and is bullish now.

In this weekly bar chart of TNDM, below, we can see how the stock collapsed from $110 to nearly nothing! A near death experience. Today prices are above the rising 40-week moving average line.

Volume has moved up with prices, the weekly OBV line is bullish as is the weekly MACD oscillator.

In this Point and Figure chart of TNDM, below, we can see an upside price target of $114 being projected.

Bottom line strategy: Our Point and Figure chart is showing us a $114 price target but the real question is what do we risk to go long here? Probably a close below $55.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Healthcare | Pharmaceuticals

More from Investing

Let's Shine a Light on Lucid Motors as It Slides Downhill

Brad Ginesin
Jul 2, 2022 1:00 PM EDT

LCID's market cap has been deflated, so is it now a bargain, or can it slip further?

Stop Wishing, Hoping and Praying and Take Control of Your Investing

James "Rev Shark" DePorre
Jul 2, 2022 10:00 AM EDT

The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.

If You've Got Time, These Three Dividend Aristocrats Should Pay Off

Bob Ciura
Jul 2, 2022 7:30 AM EDT

There high-growth dividend stocks will be here over the long haul.

Welcome to Second Semester on Wall Street, Here's How to Make the Grade

Jim Collins
Jul 1, 2022 4:36 PM EDT

Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.

We Got a Break, but the Heat Is Still On

James "Rev Shark" DePorre
Jul 1, 2022 4:22 PM EDT

A limited rally cooled some of the negativity on the market, but guess what's going to hit the fan soon?

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:49 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Stop Wishing, Hoping, and Praying and Take Control...
  • 07:59 PM EDT PAUL PRICE

    Very Good Quarterly Numbers From Bassett Furniture (BSET)

    Bassett Furniture blew right through analysts es...
  • 04:41 PM EDT PAUL PRICE

    First-Half Results - Putrid; Second Half Results - Likely to Be Much Better

    It's great that we're done with June. 2022 mark...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login